These are all of our big past events. The details include featured speaker, sponsors and more.


 Chemistry of Wine Fundraiser


"Chemistry of Wine" Tasting & Fundraiser

Join us for an entertaining and educational evening with expert wine educator and chemistry professor, Dr. J. Ernest Simpson. Explore the whys and hows of your favorite wines with this structured lecture and wine tasting. Whether you’re the experienced oenophile or the wine lover “in waiting,” this event is sure to be a pleasure for all. Proceeds support our nanoscience STEM education programs.

The lecture will include an overview of wine and wine making and more detailed descriptions of the chemical composition of grapes and wine, laboratory methods for analysis of grapes and wines, sensory and organoleptic methods used for wine, the role of tannin and other phenolic compounds in wine, and some potential health aspects of wine.

Combined with the lecture is a "component and varietal analysis". During the component analysis, the audience will be given a reference wine sample with known levels of components such as acid, sugar, alcohol, etc. and then "unknown" samples in which one or more components have been increased by a known increment. During a varietal analysis a representative number of white and red wines will be compared.

Who Should Attend

K-12 STEM Education Supporters, Thought-leaders, Wine Enthusiasts, Science Enthusiasts, Interested members of the general public, Professionals and Entrepreneurs from all industries, Service Providers, Academic Faculty and Students.

Professor J. Ernest Simpson, Ph.D.

Dr. J. Ernest Simpson

Dr. Simpson joined the Chemistry Department at California State Polytechnic University, Pomona, in 1968 after completing his B.S., M.S., and Ph.D. (organic chemistry) at the University of New Mexico and spending one year as a visiting chemistry professor at Pomona College. In 1973-74 he was on leave as visiting research associate in the Department of Enology and Viticulture at UC/Davis.

He is an active member of the American Society for Enology and Viticulture and has served on the editorial review board for the Society's journal. He has published a California wine guide. He is a member of the Society of Wine Educators and the American Wine Society.

At Cal Poly he developed industrial chemistry and cooperative education courses/programs. He was the Director of Cooperative Education for Cal Poly (1980-2001). His research interests are in the areas of polycyclic aromatic hydrocarbons, carbon-13-labeled compounds, and phenolic compounds, especially in grapes and wine. At Cal Poly he has been selected for exceptional merit service awards including the 2013 Provost's Award. In 1996 he was selected as the outstanding advisor in the College of Science, and his co-op program was chosen as the best in California.

He is a member of ACS (San Gorgonio past chair and current councilor), California Association of Chemistry Teachers (program chairman and southern section president, 1985-87), and California Cooperative Education Association (president 1996-97). He was selected as an ACS Fellow in 2012, and serves on the ACS National Local Section Activities Committee. Dr. Simpson was named as an ACS Fellow in 2012 and in 2013 received the Provost's Award for Excellence in Service at Cal Poly Pomona.



Fighting Superbugs with Nanosponge Technology

"Each year, nearly two million people are infected with an antibiotic resistant “super bug” of one type or another. Out of these, 23,000 will die."

Here’s the wake up call to everyone: Remember getting streptococcus? Remember how rare getting staph infection used to be, and how easy it was to treat it? Many strains of staph and strep are now becoming “superbugs”. Our everyday illnesses now need antibiotics and the ones that needed antibiotics need stronger antibiotics, or they don’t even work at all.

In September, the Centers for Disease Control sounded the alarm:

Unless we stopped misusing and overusing antibiotics, they could become useless against disease-causing bacteria that are becoming resistant to them - evolving into so-called "superbugs."
One of the most common superbugs is MRSA, a staph infection that kills an estimated 19,000 Americans each year, mostly in hospitals and convalescent facilities.

MRSA (methicillin-resistant Staphylococcus aureus) is known to be difficult to treat with standard types of antibiotics and thus more dangerous. Beyond hospitals and healthcare facilities, places such as locker rooms and gyms, pediatric settings, or military recruits’ barracks among others have also reported cases.

Join us for an exciting presentation by Dr. Liangfang Zhang, Professor, NanoEngineering, UC San Diego, whose research has led to the development of the ‘nanosponge vaccine’. These nanoengineered bio-compatible particles are designed to soak up a dangerous pore-forming toxin produced by MRSA and could serve as a safe and effective vaccine against this toxin. Learn how these nanoparticles could also be effective in detaining several toxins at once and fight other pore-forming toxins from staph to snake venom.

Professor Liangfang Zhang, Ph.D.

Liangfang ZhangProfessor Liangfang Zhang, Ph.D., Ph.D. is Associate Professor, Department of Nanoengineering and Moores Cancer Center, University of California, San Diego.

Liangfang works on the design, synthesis, characterization, and evaluation of lipid- and polymer-based nanostructured biomaterials. One specific interest lies in developing nanomaterials for healthcare and other medical applications, for example, drug delivery to improve or enable treatments of human diseases. In addition, he also seeks to understand the fundamental sciences underlying the arenas of nanomedicine. Overall, his research covers a broad scope of multidisciplinary areas including chemical & molecular engineering, materials science, chemistry, nanotechnology, biotechnology, and medicine.

Currently, he is interested in three specific topics: (1) developing multifunctional lipid-polymer hybrid nanoparticles as a robust drug delivery platform that combines the merits of liposomes and polymeric nanoparticles; (2) simultaneously delivering multiple drugs with different hydrophobicity to the same cancer cells for combination therapy; and (3) understanding how single nanoparticles with distinct characteristics interact with biomembranes, with special focus on understanding cellular endocytosis and endosome escape of therapeutic nanoparticles.

Liangfang coauthored Quantum Dot-Aptamer Conjugates for Synchronous Cancer Imaging, Therapy, and Sensing of Drug Delivery Based on Bi-Fluorescence Resonance Energy Transfer, Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers, How to Stabilize Phospholipid Liposomes (Using Nanoparticles), Slaved diffusion in phospholipid bilayers, and Self-Assembled Lipid — Polymer Hybrid Nanoparticles: A Robust Drug Delivery Platform.

Liangfang earned his BE and MS in Chemical Engineering at Tsinghua University, China in 2000 and 2002, respectively. He earned his Ph.D. in Chemical Engineering at the University of Illinois at Urbana-Champaign in 2006, and did his Postdoc at the Massachusetts Institute of Technology (MIT) from 2006 to 2008.

Read Nanoparticles play at being red blood cells and Scientists Develop Nanoparticles Cloaked with Erythrocyte Membranes.

KMOB logo1_sm


“Nanotechnology in 2020 – What Can We Expect?

Program Overview

NanoTecNexus opens a new chapter in this relaunch event where it will unveil an expanded mission and new strategic direction.  Over a decade has gone by for research and development in nanotechnology worldwide and significant progress paves the way for a clearer indication of its potential.  With exciting prospect com new challenges. 

What are the expected targets for nanotechnology in 2020 and how will they be met in context of societal needs and other emerging technologies?

How will NanoTecNexus respond and address the educational needs in the next decade?

This forum will answer those questions from a market, education and scientific research perspective.


“Investing in Women –Increasing Opportunities for Funding Women”

Program Overview

Female founded startups can contribute to the rebuilding of our economy.  Forget changing corporate cultures and instead set out to change the world through your own business.  As the world becomes “smaller” and “flatter” we have a tremendous opportunity to transform and improve the way business works.  In 2011, there was an estimated 8.1 million women-owned businesses generating $1.3 trillion in revenues and employing nearly 7.7 million people. Still, venture backed women-led companies represent less than 10% of venture funding.

This forum gathers a panel of investors to discuss the start-up funding gap, why it exists and why it must change.  The panel will also provide perspective on the unique benefits and competitive advantages that women-led businesses possess and why there is an increased interest in investing in female entrepreneurs.

Moderator: Pemo Theodore, Founder, EZebis


Monica Dodi, Managing Partner, Women Venture Capital Fund

Mark Suster, General Partner, GRP Partners

Barbara Bry, COO, Blackbird Ventures

Amy Errett, Partner, Maveron LLC


A NanoTecNexus Supported Forum — OCTANe will host the Fifth Annual Medical Device and Investor Forum in Orange County at the Marriott Newport Beach. This exciting event will draw an array of industry entrepreneurs, corporate leaders and R&D executives, as well as university scientists, researchers, and venture capitalists.

More than ever, companies and individuals must remain at the leading edge of innovation in the medical device industry to maintain a competitive advantage in the US and around the world. This is the Forum to connect with industry leaders; understand the latest advancements and trends; meet those to fund or license technology; and hear about critical developments in legal issues, regulatory, design and global opportunities for medical device companies. We anticipate 800+ participants at this event (the past three years have sold out) and encourage early registration to secure your space.  Register here.


NanoTumor Center Seminar Series Presents: “Viral Nanoparticles (VNPs): Tools for Application in Biomedicine”

The use of nanomaterials has the potential to revolutionize materials science and medicine. Currently, a number of different nanoparticles are being investigated. Viral nanoparticles (VNPs) derived from plant viruses, such as the Cowpea mosaic virus and Potato virus X, can be regarded as naturally occurring nanomaterials.

Speaker: Nicole F. Steinmetz, PhD, Research Scientist and Author, The Scripps Research Institute, Department of Molecular Biology

Location: Moores UCSD Cancer Center, Goldberg Auditorium, 3855 Health Sciences Drive, La Jolla, California 92093


Nanopalooza at the San Diego Science Festival

Explore the wonderful world of smalltech – nanotech that is!!  Join us at the San Diego  Science Festival Expo and ‘excite your mind’ with fun activities, games and experiments.  Learn what makes nanotech special, what types of career opportunities there are in this field, and what type of nanotech-enabled products exist today and are coming in the future.

Location: PETCO Park, 100 Park Boulevard, San Diego, CA 92101

Booth #RF23-RF24 (Right Field)


International Nanotechnology Symposium – “Automated Virus Detection and Analysis for Applications from Oncology to Bio-Weapon Defense”

July 28, 2009 — 9am-4:30pm with reception following

The symposium will gather experts from France, Mexico and throughout the United States to discuss pioneering approaches employing a high-resolution DMA (Differential Mobility Analyzer), a physical detection method that can be applied to many virus species, particles, and ions in the environment as well as oncology patients and at-risk populations. The availability of physical methods for rapid, reliable, and complete detection of nano-particles opens up a new era in early detection of disease and environmental threats.

Attendees can expect to learn how this innovative technology works, hear examples of a wide array of applications, and first-hand insight on an A-H1N1 case study. A live demonstration of the technology and a poster session is included in the day’s activities with a reception at the conclusion.

Location: Moores UCSD Cancer Center, 3855 Health Sciences Drive, La Jolla, Ca 92093


 The Experimental Man Project

In this age of awakening over human and environmental impact from existing and new products and materials, author David Duncan takes “guinea pig” journalism to the very edge of science, building on award-winning articles he wrote for Wired and National Geographic, in which he tested for hundreds of chemical toxins – from pesticides to plastic additives – and millions of genetic markers associated with disease, emotions, and other traits. The idea is to humanize the science by using the example of one person as a kind of everyman assessing not only this bold new world of self-discovery, but also the impact emotionally and philosophically of knowing so much about oneself. In his new book, EXPERIMENTAL MAN: What One Man’s Body Reveals About His Future, Your Health, and Our Toxic World (Wiley, March, 2009), he expands on these tests, he examines his genes, environment, brain, and body, exploring what they reveal about his and his family’s future health, beliefs, attitudes, and behavior, and his ancestry, as well as the profound impact of this new self-knowledge on what it means to be human.

Speaker: David Ewing Duncan

Location: Mintz and Levin,3580 Carmel Mtn Road, San Diego, California 92130


Nanopalooza! – San Diego Science Festival Event

Get a BIG brain by learning about smalltech – nanotech that is!!!  Join us at the San Diego Science Festival Expo at the Nanopalooza booth where we will have fun activities, games and experiments.  Learn what makes nanotech special, what types of career opportunities there are in this field, and what type of nanotech-enabled products exists today and are coming in the future.  Our booth #623 will have fun for all ages and examples of how nanotech impacts everything from consumer and industrial goods to medicine to clean water and sustainable energy.

Location: BOOTH #623 (Federal Lawn) at Balboa Park, 1549 El Prado, San Diego, California 92101   [See map image here: View this photo ]


Nanotech Mashup!

This unique event features a keynote from industry expert, Josh Wolfe.  His talk, “Nanotech, Megamillions: Fortune, Fame, Failures, & Folly–A Contrarian View from a Venture Capital Investor” is one you should not miss.  In partnership with the NanoTumor Center, we invite you to come and meet cutting-edge nanotech researchers and scientists from various departments at UCSD in this special “mashup’ reception. Attendees will have the opportunity to engage in conversations with researchers from the chemistry, medical, physical sciences, engineering, physics and other disciplines who are all working together in innovative applied and translational nanotech research. Hands on demonstrations, videos and educational materials will be available to provide.  Join us for this unique opportunity to learn more about these innovative technologies and how they address some of the world’s toughest challenges from medicine to energy.

Speakers: Josh Wolfe, Co-Founder and Managing Partner, Lux Capital [Download Josh Wolfe Bio & pic]

Location: Hilton Garden Inn, 3939 Ocean Bluff Ave, San Diego, California 92130


NanoArt Exhibit!

The invisible becomes visible……..NanoArt is a unique new art discipline created by artists and scientists where microscopic images of scientific strauctures are captured and processed using precise techniques to convert these structures into colorful art.  The micro and nanosculptures (molecure and atomic scale sculptures) are created using chemical and physical processes and visualized with powerful research tools like scanning electron or atomic force microscopes.  In support of the San Diego Science Festival, we have arranged this unique exhibit for people of all ages.  No registration reguired for this event.  Visit library website for daily hours of operation.

Location: Mission Valley  Library, 2123 Fenton Parkway, San Diego, California 92108


Next Generation Power via Man-Made Nanomotors and Nano-enabled Alternative Energy Technologies

New sources of energy are critically important to power our future and our economy. Where will these new sources of alternative energy come from? What novel materials will work best? The remarkable performance of biomotors is inspiring scientists to create synthetic nanomachines that mimic the function of these amazing natural systems. This presentation will discuss the challenges and opportunities facing artificial nanomotors. While artificial nanomotors pale compared to nature biomotors, recent advances indicate significant improvements in the velocity, motion control, cargo-towing force and lifetime of such catalytic nanomotors. The improved performance of chemically-powered artificial nanomotors could pave the way to exciting and important applications and to sophisticated nanoscale devices performing complex tasks. Join us for this exciting program featuring lead-edge nanotechnologies from world renowned nanotech experts.


Ken Vecchio, Ph.D. , Professor and Chair Nanoengineering, UCSD

Joseph Wang, Ph.D., Distinguished Professor, Nanoengineering, UCSD

Location: Mintz and Levin,3580 Carmel Mtn Road, San Diego, California 92130


Clearing the US and EU Regulator Path to Product Approval – “What Similarities and Differences Exist and How Can Companies Manage the Hurdles?” (Webcast Unavailable)

Learn how to navigate through the complexities and policy changes that biotech and nanotech products face today. Expert advice and case studies will provide valuable lessons on how policy and regulation is influencing technology in the US and EU and what companies can do to save time and cost throughout the process.


  • Ricardo Carvajal, Esq., Of Counsel, Hyman, Phelps & McNamara, P.C.
  • Kjell Srandberg, M.D., Ph.D., Advisory Board Chairman NDA, Regulatory Consultant Service AB., Former Director General of the Swedish Medical Products Agency & member of CPMP
  • Michael A Swit, Esq., Vice President, The Weinberg Group Inc.


“Center for Nanosciences and Nanotechnology at Universidad Nacional Autonoma de México (UNAM) Ensenada” (Webcast Unavailable)

The debut of UNAM Ensenada’s Center for Nanoscience and Nanotechnology marks the trend of newly inaugurated departments focused on nanotechnology in universities around the world. UNAM is already recognized as the university with the highest concentration of researchers working on nanotechnology and some of the most ambitious projects. At UNAM Ensenada this announcement ties into an overall vision for the region that includes vinculation, innovation and economic sustainability through industrial applications of breakthrough technology.


  • Nina Bogdanchikova, Ph.D., Principal Investigator, UNAM
  • Sergio Fuentes, Ph.D., Director of the Center for Science of Condensed Matter, UNAM (CCMC-UNAM)


Holiday and NanoArt Extravaganza

Join us for holiday cheer and a unique opportunity to feed your mind and your soul with a two-part holiday extravaganza. First the NanoTumor Center will host a nanotech forum with exciting speakers (see below). Immediately following, celebrate the holidays with fine food, festive beverages and a special preview exhibit and sale of NanoArt hosted by world renowned Cris Orfescu. A portion of the proceeds will support NBN outreach programs. Also join us in the spirit of giving and support the “Toys for Tot” toy drive by bringing a new unwrapped toy. The celebration starts at 6pm.


Nanoparticles for Targeted Gene and Drug Delivery – “From Manufacturing to Market Applications” (Webcast Unavailable)

Custom chemistry and nanofabrication is essential to a wide range of biomedical applications that require binding of enzymes, antibodies, or cells to micro or nanofabricated materials. Bringing these biomedical applications to market present its own set of challenges. Join us to learn how fabrication and commercialization challenges are being addressed by experts dedicated to making these novel applications a reality. The speaker presentations start at 4:30pm.


  • Mirianas Chachisvilis, Ph.D., Assistant Professor, La Jolla Bioengineering Institute
  • William Trogler, Ph.D.,  Fabrication Core Co-Leader, NanoTumor Center, Professor, Chemistry & Biochemistry, Translational Oncology Program, University of California, San Diego
  • Mark S. DiIorio, Ph.D., President & CEO, Chairman of the Board, MagneSensors


Bionano Materials and Tissues (Webcast Unailable)

There is increased attention and significant research in the design and synthesis of new biocompatible materials for tissue engineering, tissue regeneration and new therapeutic methods to restore the anatomic structure and function of damaged, injured or missing tissue. Join us and learn about the progress and findings in this exciting area of material science and where we stand in our understanding of molecular interactions between materials and organisms.


  • Song Li, Ph.D., Associate Professor, Department of Bioengineering, University of California, Berkeley
  • Thomas Webster, Ph.D., Associate Professor of Engineering, Brown University


NanoBioNexus Third Year Anniversary Reception Gala

Join us for our premier event of the year as we celebrate another year of achievement while recognizing the thought leaders that have supported the organization.


Nanotoxicology –”What Has Been Learned So Far?”

Although humans have been exposed to airborne nanoparticles for years through traditional anthropogenic sources, evidence shows that the exposure has dramatically increased in the last century. In this nano-age, are engineered nanoparticles better or worst than those we are accustomed to? What is being done to understand their impact on humans and the environment? Tremendous efforts are ongoing worldwide to increase our understanding of this subject. Join us for this provocative session and hear what the experts have to say and what has been learned so far.


  • Martin Philbert, Ph.D., Professor, Environmental Health Sciences, Senior Associate Dean, University of Michigan, School of Public Health
  • Stephen B Howell, M.D., Professor of Medicine, UCSD, Director, Cancer Pharmacology Program, Moores UCSD Cancer Center, Core Leader, NanoTumor Center


Patenting and Licensing Nanotechnology – “Where Much Can Go Wrong if You Don’t Get it Right”

To borrow a phrase, “Wake Up and Smell the IP”, IP management and protection has become one of the hottest issues in corporate America due to Sarbanes-Oxley. Nanotechnology patent applications rank as the fastest growing category in the US Patents and Trademark Office (USPTO) and the backlog is at it’s highest in its history. How do these trends relate to each other? How do they impact: Inventors wanting to protect their inventions; Entrepreneurs wanting to start a new company; or Large company exec wanting to acquire new technologies? Most often, the make or break for success will depend on how well you covered your bases. Join us to learn valuable and practical insights on the realities and risks associated with existing processes, business and acquisition trends and legal frameworks and what you can do to mitigate your risks.


  • Esther Kepplinger, Director, Patent Operations, IP Counseling & Patents, Wilson Sonsini, Goodrich & Rosati Law Firm
  • Jane Moores, Ph.D., Interim Director, UCSD TechTips
  • Vicki G Norton, Ph.D., JD, Partner, Intellectual Property, IP Litigation, IP Counseling & Patents, Life Sciences, Wilson Sonsini Goodrich & Rosati Law Firm


Nanotechnology in Drug Delivery – “How Close Are We?”

Pharmaceutical scientists expend much effort in finding ways to selectively target therapeutics because, each year, billions are spent on pharmaceuticals with poor bio-availability which not only results in higher patient costs and inefficient treatments, but also in increased risks of toxicity and even death. Nano-enabled drug delivery may eliminate the pharmacokinetic difficulties because of its potential to better deliver drugs to defined areas and permeate through cell walls, facilitate solubility, and prevent rapid breakdown and/or clearance of drugs in vivo. Come join us to hear the highlights of the major nano-enabled drug delivery technologies that are commercially available or under development.


  • Michael Sailor, Ph.D., Professor, Department of Chemistry and Biochemistry, UCSD
  • Don Ackley, Ph.D., CEO, Nanotrope, Inc.
  • Martin Woodle, Ph.D., Chief Scientific Officer, Intradigm Corporation


Building a Successful Nanotech Company – “What Will it Take in Today’s Market?”

What does it take to create and operate a successful nanotech company in today’s competitive landscape? How is the journey of a nanotechnology entrepreneur different from or similar to the path of a conventional technology start-up? These and many other questions will be pondered by a distinguished panel of nanotechnology executives, veteran entrepreneurs, venture capitalists, and financiers. Discussion topics will include sources of technology acquisition and early stage funding, typical exit strategies for a nanotechnology start-up, alternative financing models, anticipated industry trends, and many more. Program will be preceded and followed by a lively reception with ample opportunity to network.


  • Mark Bünger, Director of Research, Lux Research
  • Steven Oldenburg, Founder and CEO, nanoComposix, Inc.
  • Julian L. Zegelman, JD, Partnerships and Alliances Director, NBN Consultant
  • Kevin D. Maloney, Co-Founder, President and CEO, QuantumSphere, Inc.


Nanotechnology in Cancer Research – “How Will Centers forCancer Nanotechnology Excellence (CCNE’s) Make a Difference?” (Webcast Unavailable)

The National Cancer Institute (NCI) set aside $144 million in 2004 for the creation of eight centers of cancer nanotechnology excellence with steep mandates and complex requirements. Join us to learn how this novel approach will help impact the chances of success in the fight against cancer. San Diego-based NanoTumor Center leaderswill share the progress on top research projects and plans for commercialization.


  • Sadik Esener, Ph.D., Principal Investigator and Center Director. Professor, Electrical & Computer Engineering, University of California, San Diego
  • Dennis Carson, M.D., Professor of Medicine, Translational Oncology Program, University of California, San Diego; Director, Moores UCSD Cancer Center; Chugai Pharmaceutical Chair in Cancer; NanoTumor Center Project Leader and Executive Committee Member
  • David Cheresh, Ph.D., Project Leader. Professor, Pathology, Cancer Biology Program, University of California, San Diego


Canada’s Nanotech Innovation and Commercialization Models

Canada has been at the forefront of Nanotechnology Research and Development for years. Significant investment for the development of infrastructure is the hallmark of strategic initiatives in place across regions like Alberta, British Columbia, Ontario and Quebec. Join us to learn about these innovative programs and models for collaboration and commercialization and what this can mean to companies and researchers worldwide.


  • Rajan Gupta, Ph.D., Founder and CEO, SciMed Laboratories Inc.
  • Hua Q. Yin, M.D., Ph.D., Associate Director, Life Sciences NUCRYST Pharmaceuticals, Alberta Canada
  • David J Cox, Ph.D., President and CEO, TEC Edmonton, Canada
  • Nils Petersen, Ph.D., Director General, National Institute for Nanotechnology (NINT), National Research Council, Canada
  • Alain Dudoit, Consul General, Canadian Consulate General in Los Angeles


Second Year Anniversary Reception Gala

Join us for an evening of networking and help us celebrate the second anniversary of the NanoBioNexus organization. This will be an excellent opportunity to spend some quality time and get to know other thought-leaders from the business and scientific communities that are interested in cutting-edge nanosciences.


Investing in Nanotechnology- “Too Early or Too Late?”

This year is expected to be the first in which the money put into nanotechnology R&D globally by industry will exceed that coming from government. What does this mean for investors? Where and what are the nanotech investment opportunities today? A panel of experts will share their insights into the nanotech investment arena.


  • Scott Livingston, Managing Director, The Livingston Group, Axiom Capital Management Inc.
  • Larry Bock, MBA, Special Limited Partner & Chairman of Lux Ventures’ Advisory Board Lux Capital Management
  • Terry Moore, MBA, Strategic Business Director
  • Joel Martin, Ph.D., Partner, Forward Ventures


Targeted Nanotherapeutics and Molecular Imaging – “How Will This Change The Face of Medicine?”

Although some of the applications for nanomedicine are quite futuristic, others are on the verge of generating significant revenues. Nanotherapeutics involves the treatment of disease using techniques and technologies developed at the nanoscale. Join us to learn how nanotherapeutics and molecular imaging will help lead to better methods of studying biological processes and manage diseases.


  • Marianne Manchester, Ph.D., Associate Professor, Department of Cell Biology, Center for Integrative Molecular Biosciences, The Scripps Research Institute
  • Michael J. Natan, Ph.D., President, Oxonica, Inc. (formerly Nanoplex Technologies, Inc.)


Nanofabrication – “What Can Self-Assembly Do For Nanotech Applications?”

This seminar is focused on creating nanoscale architectures through molecular recognition and self-assembly. How will this impact nanotechnology applications and what is the significance of self-assembled structures?


  • Cengiz S. Ozkan, Ph.D., Assistant Professor, Bourns College of Engineering, University of California, Riverside
  • Mihri Ozkan, Ph.D., Director, Biomedical Science & Nanotechnology Lab, Assistant Professor of Electrical Engineering, UC Riverside


Nanotoxicology – “How Are Potential Risks Being Addressed?” (Webcast Unavailable)

The FDA expects that many of the nanotechnology products will span the regulatory boundaries between drugs, medical devices and biologicals. Learn how these and other issues around policy and public perception are being addressed. Is the chemical characterization of nanoscale materials available today complete? Are traditional approaches and study protocols sufficiently robust to do the job?


  • Kevin Ausman, Ph.D., Executive Director for Operations, Center for Biological and Environmental Nanotechnology, Rice University
  • Paul C. Howard, Ph.D., Division of Biochemical Toxicology, FDA, National Center for Toxicological Research


Managing Business Risk – “Side-stepping The Minefields of Nanotech Commercialization”

With an incredible amount of government and industry funding for nanotechnology innovations, entrepreneurs and inventors can capitalize on commercialization opportunities like never before. If it sounds easy, think again. Join us for an eye-opening discussion on the defining realities and risks associated with this field that will determine success or failure for new ventures.


  • Jim Clements, M.S., MBA, Principal and VP Business Development, NanoSciences, Inc.
  • Jeffrey Krohnfeldt, President & CEO, K Street Ventures/GroundFloor Bio
  • Kevin D. Maloney, Co-Founder, President and CEO, QuantumSphere, Inc.
  • Carolyn A. Favorito, JD, Associate, Morrison & Foerster LLP
  • Nobuyuki Kambe, Ph.D., Vice President and Chief Technical Officer


Nanotech Enabled Drug Discovery and Drug Delivery – “Is this Pharma’s Latest Cure?”

High patient costs, inefficient treatments and risks of toxicity or even death are putting immense pressures on pharmaceutical and biotech companies to produce a steady stream of affordable, yet innovative and well-differentiated drugs. Will nanotechnology be the means for improving drug discovery and drug delivery systems to create new profitable products for these companies?


  • Michael Sailor, Ph.D., Professor, Department of Chemistry and Biochemistry, UCSD
  • Cathy Owen, President, Nanopoint Inc.


NanoBioNexus 1st Year Anniversary Reception

You are cordially invited to join us for a networking reception celebrating the first year anniversary of NanoBioNexus organization. This will be an excellent opportunity to spend some quality time networking with business and scientific leaders.


Nanotech in Bioanalysis and Diagnostics – “Who will win, who will lose?”

Learn about the many innovative ways nanotechnology is being implemented for bioanalytical and diagnostic products. Will a new class of products and companies emerge and leapfrog the competition? How can these products improve drug discovery and what is the downstream impact on patient care?


  • Michael D. Burkart, Ph.D., Assistant Professor, Chemistry & Biology University of CA San Diego, La Jolla, CA
  • Bill Van Antwerp, VP and CSO Medtronic Minimed, North Ridge, CA
  • Mark S. DiIorio, Ph.D., President & CEO, Chairman of the Board, MagneSensors


Nanofabrication – “Can we Harness Nature’s Self Assembly?”

Human repair can be accelerated significantly with the use of nanotechnology-enabled materials and the process of molecular recognition. Join us for a discussion on what it will take to manufacture these technologies. Are we up to the task to truly regenerate bone, vision, hearing or hair?


  • Don Ackley, Ph.D., CEO, Nanotrope, Inc.
  • Manish Mehta, Ph.D., Director, Collaborative Programs and Principal Investigator, NCMS-NSF Nanomanufacturing Industry Survey Project National Center for Manufacturing Sciences (NCMS)
  • Michael J. Heller, Ph.D., Professor, Departments of Bioengineering and Electrical and Computer Engineering (ECE), UCSD


Nanobiotechnology – “A Historic Look and Peek into the Future” (Webcast Unavailable)

Join us for an educational segment on the history of nanobiotechnology and a lively discussion on where current breakthroughs take us as the New Year unfolds. What can we expect in the near term, three-to-five years, and beyond?


  • Stephen Barry, Ph.D., President, Alnis BioSciences, Inc.
  • Philip Reilly, JD, Ph.D., Vice President and General Counsel, MacuSight, Inc.
  • Sangeeta Bhatia, M.D., Ph.D., Director, Laboratory for Multiscale Regenerative Technologies; Associate Professor Health Sciences and Technology/Electrical Engineering & Computer Science, M.I.T; Department of Medicine, Brigham & Women’s Hospital
  • Hans Coufal, Ph.D., Manager of Science and Technology, IBM Almaden Research Center


Nanotechnology in Cancer Research – “How Far Have We Come?”

The application of nanotechnology to cancer research is particularly attractive for its potential to deliver innovative tools that can transform promising molecular discoveries into benefits for cancer patients. The National Cancer Institute recently announced a new $144.3 million, five-year initiative to support cancer research using nanotechnology. How will the latest NCI initiative accelerate progress in nanotech cancer programs?


  • Gregory J. Downing, D.O., Ph.D., Director, Office of Technology and Industrial Relations, National Cancer Institute (NCI)
  • Mihri Ozkan, Ph.D., Director, Biomedical Science & Nanotechnology Lab, Assistant Professor of Electrical Engineering, UC Riverside
  • Erkki Ruoslahti, M.D., Ph.D., Distinguished Professor and former President, Burnham Institute


Commercialization of Nanobiotechnology – “Defining the Market for a Nanotech Spinout”

When is nanotechnology ready to become a spinout and leave the research lab’s nest? What needs to be done to protect trade secrets and intellectual property? What will it take to succeed at the early stage, mid-stage and late-stage of a spinout’s life? Join us for an enlightening presentation from actual nanotech spinout companies and the institutions in place to enable nanotech commercialization.


  • Derrick Boston, JD, Senior VP, California Nanosystems Institute
  • Goran Matijasevic, Ph.D., MBA, INRF Research Coordinator, Integrated Nanosystems Research Facility, UCI


Nanobiotechnology – Fact or Fiction?

A panel of experts share their methods for sifting through the hype and misinformation about nanotechnology in the life sciences. A planned cross section of perspectives was chosen for this event. They include investment, commercialization, legal and academic.


  • Michael J. Heller, Ph.D., Professor, Departments of Bioengineering and Electrical and Computer Engineering (ECE), UCSD
  • Michael Lynch, Product Manager, BioForce Nanosciences, Inc.
  • Jeffrey Krohnfeldt, President & CEO, K Street Ventures/GroundFloor Bio
  • Philip Reilly, JD, Ph.D., Vice President and General Counsel, MacuSight, Inc.